Atherosclerosis, characterized by atherosclerotic plaques, is a complex pathological process that involves different cell types and can be seen as a chronic inflammatory disease. In the advanced stage, the ruptured atherosclerotic plaque can induce deadly accidents including ischemic stroke and myocardial infarction. Epigenetics regulation, including DNA methylation, histone modification, and non-coding RNA modification. maintains cellular identity via affecting the cellular transcriptome. The epigenetic modification process, mediating by epigenetic enzymes, is dynamic under various stimuli, which can be reversely altered. Recently, numerous studies have evidenced the close relationship between atherosclerosis and epigenetic regulations in atherosclerosis, providing us with a novel perspective in researching mechanisms and finding novel therapeutic targets of this serious disease. Here, we critically review the recent discoveries between epigenetic regulation mechanisms in atherosclerosis.
Cerebrovascular ageing is a complex process characterized with increased vessel stiffness, decreased sensitivity to vasodilators and vasoconstrictors, and reduced angiogenesis, which is mediated via time-dependent manner. The triglyceride-glucose (TyG) index, calculated by ln[fasting triglycerides (TG) (mg/dl) × fasting blood glucose (FBG) (mg/dl)/2], has recently been evidenced as a reliable surrogate of insulin resistance (IR). Currently extensive studies provide robust statistical evidence of the predictability of the TyG index in the development and prognosis of ageing-related cerebrovascular diseases. Yet the application of the TyG index in ageing-related cerebrovascular diseases has not been systemically evaluated in clinical practice, and also the underlying shared mechanism has not been disentangled. Therefore, revealing novel treatment strategies and identifying the potential mechanisms targeting the TyG index is of significant importance. On this basis, more studies are warranted to standardize the optimal care taken in clinical referring TyG index, which will benefit patients with high cerebrovascular diseases risk. Here, we searched the Cochrane Library, Embase, Medline, Web of Science, PubMed, and other relevant English databases and related websites from inception to August 2025 and reviewed existing literature and describe the current scope and impact of the TyG index on ageing-related cerebrovascular diseases, aiming to highlight its application value and underlying mechanism.
Bone morphogenetic protein belongs to transcription growth factor superfamily β; bone morphogenetic protein signal pathway regulates cell proliferation, differentiation, and apoptosis among different tissues. Cerebrovascular system supplies sufficient oxygen and blood into brain to maintain its normal function. The disorder of cerebrovascular system will result into serious cerebrovascular diseases, which is gradually becoming a major threat to human health in modern society. In recent decades, many studies have revealed the underlying biology and mechanism of bone morphogenetic protein signal pathway played in cerebrovascular system. This review will discuss the relationship between the two aspects, aiming to provide new perspective for non-invasive treatment and basic research of cerebrovascular diseases.
21 May 2022 in Clinical Neurology and Neurosurgery
To compare the safety and efficacy of low profile visualized intraluminal support (LVIS) stent-assisted hydrogel coil embolization and LVIS stent-assisted bare platinum coil embolization for acutely ruptured wide-necked intracranial. 89 patients who underwent LVIS stent-assisted hydrogel coil embolization (hydrogel coil group) and 145 patients who underwent LVIS stent-assisted bare platinum coil embolization (platinum coil group) were retrospectively reviewed after 1:2 propensity score matching (PSM). Procedure-related complications, clinical and angiographic follow-up outcomes were compared between the two groups. All baseline characteristics were equivalent between hydrogel coil group and platinum coil group after PSM. There were no statistical differences in immediate postoperative embolization results, clinical and angiographic follow-up outcomes between the two groups (P = 0.514, P = 0.323 and P = 0.949, respectively). Intraprocedural aneurysm rupture, intraprocedural thrombosis and postprocedural thrombosis occurred in 2 patients (2.2%, 2/89), 1 patient (1.1%, 1/89) and 1 patient (1.1%, 1/89) of the hydrogel coil group compared with 1 patient (0.7%, 1/145), 1 patient (0.7%, 1/145) and 2 patients (1.4%, 2/145) of the platinum coil group, respectively (P = 0.559, P = 1.000 and P = 1.000). Nevertheless, the rate of postprocedural aneurysm early rebleeding in the hydrogel coil group was significantly lower than that in the platinum coil group (0.0% vs 4.8%, P = 0.046). LVIS stent-assisted hydrogel coil embolization may reduce the risk of aneurysm early rebleeding compared with LVIS stent-assisted bare platinum coil embolization for the treatment of acutely ruptured wide-necked intracranial aneurysms, which implies that hydrogel coil may improve the safety of stent placement for ruptured intracranial aneurysms.
28 December 2025 in CNS Neuroscience & Therapeutics
Background: Abnormally high shear stress (HSS) is strongly associated with intracranial aneurysm (IA) formation. Endothelial Piezo1 is sensitive to shear stress stimulation, but the mechanism by which it mediates this mechanobiological coupling process is unclear. Methods: The correlation between shear stress and the Piezo1 expression was investigated using human IA samples and a parallel‐plate flow chamber system. To determine the effects of endothelial Piezo1 on the phenotype of neighboring vascular smooth muscle cells (VSMCs) and IA formation, the CRISPR/Cas9 system was used to inhibit endothelial Piezo1 gene expression in vitro. Piezo1 ΔEC mice were produced by injecting AAV2‐BR1‐Tie2‐Cre into 8‐week‐old male Piezo1 flox/flox mice, which were further used to construct the IA mouse model. Single‐cell RNA sequencing and intercellular communication analyses of co‐cultured endothelial cells (ECs) and VSMCs were used to screen for receptor‐ligand pairs after inhibiting EC Piezo1 in vitro. The role of the screened receptor‐ligand pair was further validated via in vivo and in vitro experiments. Additionally, the underlying mechanisms were investigated. Result: Piezo1 expression correlated negatively with the shear stress in human IA. HSS reduced EC Piezo1 expression and promoted VSMC phenotypic transformation compared with physiological shear stress. Depletion of EC Piezo1 resulted in the VSMC phenotypic transformation and, more importantly, promoted aneurysmal vascular remodeling in the mouse IA model. The platelet‐derived growth factor subunit B (PDGFB)_Platelet‐derived growth factor receptor β (PDGFRβ) was identified as being involved in this process. Moreover, the PDGFRβ antagonist reversed the VSMC phenotypic transformation and attenuated IA progression. Mechanistically, Piezo1 depletion promoted PDGFB expression via YAP/β‐catenin pathway. Conclusion: HSS downregulates Piezo1 expression in ECs, which subsequently enhances PDGF‐BB expression through the YAP/β‐catenin signaling pathway. The elevated PDGF‐BB facilitates phenotypic transition of VSMCs via PDGFRβ binding, ultimately contributing to IA formation.
5 August 2025 in Journal of the American Heart Association
Background: The triglyceride–glucose (TyG) index is associated with various cerebrovascular diseases. However, the association between the TyG index and the instability (growth or rupture) of unruptured intracranial aneurysms (UIAs) remains underexplored. Methods: This multicenter retrospective analysis used data from 2 prospective Chinese cohorts with UIAs. Participants with UIAs were categorized on the basis of TyG (calculated by the Ln (triglycerides [mg/dL]×fasting blood glucose [mg/dL]/2) quartiles. Kaplan–Meier survival analysis was used to estimate survival disparities among the TyG subgroups. Multivariable‐adjusted Cox proportional hazards regression models and restricted cubic spline analyses were applied to assess the relationship between the TyG index and the onset of UIA instability. Results: This study included 5484 participants with UIAs with a median TyG index of 8.6 (interquartile range [IQR], 7.6–9.6). During a median follow‐up of 57.3 (interquartile range, 50.1–67.1) months, 778 (14.2%) patients developed UIA instability. Restricted cubic spline analysis revealed a linear dose–response relationship between the TyG index and UIA instability risk. The TyG index was positively associated with risk of incident UIA instability after adjusting for potential confounding factors with adjusted hazard ratios of 1.0 (reference), 2.33 (95% CI, 1.72–3.17), 2.01 (95% CI, 2.23–4.05), and 4.39 (95% CI, 3.28–5.88) for TyG index quartiles 2, 3, and 4, respectively. Similar and consistent results were obtained in sensitivity analyses ( P <0.001). Conclusions: The TyG index is independently associated with a higher risk of incident UIA growth or rupture, indicating the importance of applying the index in stratifying the instability risk of UIAs.